CellAegis autoRIC® Device, which reduces heart damage in ischemic heart disease, is now being clinically implemented in Peel-Halton Region, West of Toronto. The autoRIC® Device is being used to treat all patients having heart attacks, in addition to standard treatment. The FIRST study (Field Implementation of autoRIC Device in STEMI (ST-segment Myocardial Infarction)) is the first clinical implementation of our device across an entire region, and is expected to be the first of many such clinical implementations, as the benefit of Remote Ischemic Conditioning therapy becomes more widely utilized.

For the full press release click here

July 21, 2016 KITCHENER — A startup developing a low-cost, high-resolution digital X-ray imager to detect lung disease in developing nations has received a $1-million boost.

The new money from federally funded Grand Challenges Canada will help KA Imaging build a prototype and test it in the field in Zambia by the end of the year.

For the full article click here

For the Grand Challenges press release, click here

OBIO Innovation Agenda Leader

On July 21st, Gail Garland, CEO of OBIO attended the  Federal Government's Global Science Excellence Roundtable, part of the Inclusive Innovation Agenda Strategy held in Ottawa.

The ideas generated during the session will be consolidated and presented to Minister Navdeep Bains for consideration as part of the Inclusive Innovation Agenda report.

For the full report, click here

For the Innovation Submission page, click here

July 19, 2016 TORONTO – iTP Biomedica Corp., a developer of proprietary whole transcriptome-based cancer diagnostics, today announced the launch of BladderPredict, a groundbreaking next-generation sequencing-based test that will for the first time assist uro-pathologists in assigning disease grade in early stage bladder cancer, and urologists and uro-oncologists in managing the disease.

For the full press release, click here

July 7, 2016 - TranQool. an online platform that matches users with registered Cognitive Behavioural Therapy (CBT) therapists and lets them connect via secure video calls, was featured in Canadian Healthcare Technology magazine.

July 6, 2016 - CAAP Company Eve Medical and their CEO, Jessica Ching, are featured in the August issue of Chatelaine.

June 24, 2016 This year Toronto hosted the inaugural RESI conference on June 23, bringing together hundreds of companies and investors from across the globe in areas of biotech, digital health, medical devices and consumer health. 

June 14, 2016 - OBIO's own Dr. Klaus Fiebig, Senior Director of Strategic Programs, was asked to moderate at this years MedEdge Summit hosted in Richmond Hill.

For the video, click here (See Klaus at 1:55)

June 2, 2016 Harry Gandhi is the co-founder of Medella Health, a Waterloo-based company developing a smart contact lens that continuously monitors glucose levels (with the information transmitted to a mobile device), is hoping that its contact lens will change the way we approach the disease. The company has raised $1.4 million in funding from 1517 Fund, Fifty Years Fund, Garage Capital, and BDC Capital.

For the full story, click here

TORONTO, May 11, 2016 Johnson & Johnson Innovation announced the opening of JLABS @ Toronto, a new 40,000-square-foot life sciences incubator, providing entrepreneurs shared lab space and offices, modular lab suites and access to scientific, industry and capital funding experts as they work to build important and successful early-stage companies.